Reduction of Plasma Glutamyl Aminopeptidase Activity in Sporadic Alzheimer's Disease
- 24 February 1997
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 231 (3) , 526-530
- https://doi.org/10.1006/bbrc.1996.5920
Abstract
No abstract availableKeywords
Funding Information
- Chugai Pharmaceutical
- Ministry of Education, Culture, Sports, Science and Technology
- Naito Foundation
- Uehara Memorial Foundation
This publication has 20 references indexed in Scilit:
- The E280A presenilin 1 Alzheimer mutation produces increased Aβ42 deposition and severe cerebellar pathologyNature Medicine, 1996
- Secreted amyloid β–protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's diseaseNature Medicine, 1996
- Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor proteinNature, 1995
- Dominant and differential deposition of distinct β-amyloid peptide species, AβN3(pE), in senile plaquesNeuron, 1995
- An Increased Percentage of Long Amyloid β Protein Secreted by Familial Amyloid β Protein Precursor (βApp 717 ) MutantsScience, 1994
- Cellular processing of β-amyloid precursor protein and the genesis of amyloid β-peptidePublished by Elsevier ,1993
- Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein productionNature, 1992
- Production of the Alzheimer Amyloid β Protein by Normal Proteolytic ProcessingScience, 1992
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991
- Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndromeAnnals of Neurology, 1985